Cyclic nucleotide-gated channel subunit alpha 3 (CNGA3)

Cyclic nucleotide-gated channel subunit alpha 3 (CNGA3) is a vital transmembrane protein that forms the pore-conducting subunit of the cyclic nucleotide-gated (CNG) channels in cone photoreceptors [UniProt]. These channels play a central role in the visual phototransduction cascade by modulating the flow of sodium and calcium ions in response to changes in intracellular cGMP levels [NCBI Gene]. In the dark, high levels of cGMP keep the channels open, while light exposure leads to cGMP hydrolysis and channel closure, resulting in cell hyperpolarization [PubMed: 10611369]. Mutations in the CNGA3 gene are a major cause of achromatopsia, a condition characterized by the loss of cone function, leading to total color blindness and severely impaired central vision [OMIM: 600053]. Because the underlying retinal structure often remains intact in affected individuals, CNGA3 has become a primary target for regenerative medicine [PubMed: 32350143]. Current therapeutic efforts focus on gene replacement therapy using adeno-associated virus (AAV) vectors to deliver a functional CNGA3 gene directly to the subretinal space [ClinicalTrials.gov: NCT02610582]. These treatments aim to restore cone-mediated vision and improve the quality of life for patients with inherited retinal dystrophies.

Other names

Cone photoreceptor cGMP-gated channel subunit alphaAchromatopsia 2CCNC1CNG3CCNCalpha

Gene replacement therapy via adeno-associated virus (AAV) vector delivery to restore functional cone photoreceptor ion channels.